Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 296 million people worldwide.

Our purpose is to reimagine medicine to improve and extend people’s lives. Our vision is to become the most valued and trusted medicines company in the world. Our strategy is to deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Novartis aims to revolutionize how the world tackles cardiovascular and renal disease - transforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD), the world’s biggest killer, and ease the burden for people living with rare and progressive kidney disease by extending dialysis-free life.